| Tag | Content |
|---|
EnhancerAtlas ID | HS065-02474 |
Organism | Homo sapiens |
Tissue/cell | GM18508 |
Coordinate | chr19:6198980-6200010 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NRF1 | MA0506.1 | chr19:6199555-6199566 | GCGCCTGCGCG | + | 6.14 | | NRF1 | MA0506.1 | chr19:6199583-6199594 | GCGCCTGCGCG | + | 6.14 | | NRF1 | MA0506.1 | chr19:6199616-6199627 | GCGCCTGCGCG | + | 6.14 | | NRF1 | MA0506.1 | chr19:6199697-6199708 | GCGCCTGCGCG | + | 6.14 | | NRF1 | MA0506.1 | chr19:6199757-6199768 | GCGCCTGCGCG | + | 6.14 | | NRF1 | MA0506.1 | chr19:6199835-6199846 | GCGCCTGCGCA | + | 6.62 | | ZNF263 | MA0528.1 | chr19:6199786-6199807 | CCCCCATCTCCCCCCGCCTCC | - | 6.72 | | ZNF263 | MA0528.1 | chr19:6199779-6199800 | CCTTCCTCCCCCATCTCCCCC | - | 6.7 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_42305 | chr19:6198900-6200311 | Lung |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AAGAAGTGTC TGGTCCCTGG GGAGGAGACG GCGCCCGGCA GGGACAGTGG GCCTACAGCT 60
GACCTGTCTG CTTGCTGGTG GGTTTCCTGC TGAACTCCTC TCTGGGTCAG TGCGTCTCAC 120
TGTCCACCTG TCCCTGCATC CCCTTCTGTG CCTCGCTGGT CATCTTTCTC CCTTGGCAAT 180
CCACTTCATA CACCACGCCT CCTCCGTCTG CCATCTCTCA GTGCCACGCT CCTGCCTGTG 240
CTCCCATCTC TCCCTGGTTT TGCCCCTGAC ACGCCACCTG CTCGCCTCTC TCTAGGTCCA 300
TCTGGGGGTC TCCGGCCGCC GCTGACCCGC CTGTCCGCAG GCTGAGCTAC TCGGACCACG 360
GAGCGCGACG GGGAGGCGCG ACTGCGGCTC AGCAAGGACT AAGTTAGCAA CAAGACACTC 420
CTCACTGTGC ACGACATGGT CGCGAGCACG GCCATCAAGT ACGCCAACAA CATCGCGCCC 480
GGCTCCAACA GCTGCCACCT GCTCACCTAC ATCGAGTACC ACCAGCAGTG TCTCGGCGTC 540
GAGAAGTCTT TCTTCAAAGT ACCGCCAGGC GGTCCGCGCC TGCGCGCCCC TCCCGCCCCT 600
CCTGCGCCTG CGCGCCTCTT CTGCACCCAC CCTCTTGCGC CTGCGCGCCA CTTATTTCAC 660
CTCCTGCGCC AGCGCAGCGC TCCAGGGCCT TTCTTCCCCC GCCCCTCCCC GCGTCCTGCG 720
CCTGCGCGCC TTTCTTCCCC CGGTAAGCCT GCGCGCCGCT CCGGCCCACT TGCTTCTGCG 780
CCTGCGCGCC GCTGCAGGGC CTTCCTCCCC CATCTCCCCC CGCCTCCTAC GCCTGCGCGC 840
CACTACATCC CTTCTGCGCC TGCGCAGTGT TACTCTCCTG TGACTGCCAC TTGTCTGACT 900
CGCATGTTTG TTTTAACGGA TTCCCTGAGG CTGCCTGAGA GCCAGAAATG AAAAGCTGCA 960
GACTTAGGGG CCCTGGTTCA GATCCCAGAG CAGCCATTAG CTACGTTTTC TTGCACGAAA 1020
ACTTTGTGCC 1030
|
